KoBioLabs

KoBioLabs Equity Ratio

The Equity Ratio of KoBioLabs (348150.KQ) as of Nov 16, 2026 is 35.51 %. In the previous year, Equity Ratio was 37.14 % — a change of -4.40% (lower).

Equity Ratio

35.51 %

YoY

-4.40%

Last updated:

Equity Ratio of KoBioLabs is 2025 35.51 % . Equity Ratio of KoBioLabs was 2024 37.14 % . It decreases by -4.40% lower compared to the previous year.

The KoBioLabs Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
-127.91 KRW
Jan 1, 2019
-151.82 KRW
Jan 1, 2020
94.62 KRW
Jan 1, 2021
86.04 KRW
Jan 1, 2022
62.39 KRW
Jan 1, 2023
39.22 KRW
Jan 1, 2024
37.14 KRW
Jan 1, 2025
35.51 KRW
The KoBioLabs Equity Ratio history
YEAREquity RatioYoY
35.51 %-4.40%
37.14 %-5.29%
39.22 %-37.15%
62.39 %-27.48%
86.04 %-9.07%
94.62 %-162.33%
-151.82 %+18.69%
-127.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

Equity Ratio of KoBioLabs is 35.51 % in 2025.

Equity Ratio of KoBioLabs changed from 37.14 % to 35.51 %, representing a -4.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's KoBioLabs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — KoBioLabs

All Key Metrics — KoBioLabs